Abstract:In December, 2019, numerous unexplained pneumonia cases occurred in Wuhan, China. This outbreak was confirmed to be caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), belonging to the same family of viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).1Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; (published online Jan 24. https://doi.org/10.1016/S0140-6736(20)30183-5.)Summary Full Text Full Text PDF Scopus (32861) Google Scholar The SARS epidemic in 2003 was controlled through numerous measures in China. One effective strategy was the establishment of fever clinics for triaging patients. Based on our first-hand experience in dealing with the present outbreak in Wuhan, we have established the following clinical strategies in adult fever clinics (figure). Patients can be afebrile in the early stages of infection, with only chills and respiratory symptoms. High temperature is not a general presentation. Elevated C-reactive protein (CRP) is an important factor of 2019 novel coronavirus disease (COVID-19; formally known as 2019-nCoV) and impaired immunity, characterised by lymphopenia, is an essential characteristic. Therefore, in afebrile patients (temperature <37·3°C) without dyspnoea, we recommend measurements of complete blood count and CRP. Subsequently, if the lymphocyte concentration is ≥1100/μL, home care with self-isolation is advised. Oral azithromycin or amoxicillin can be prescribed (measure 1, figure). Chest CT is helpful (appendix) and is more sensitive than x-ray in identifying viral pneumonia. Imaging of patients with COVID-19 initially revealed characteristic patchy infiltration, progressing to large ground-glass opacities that often present bilaterally. The differential diagnosis for viral pneumonia includes respiratory syncytial virus and influenza virus. Febrile patients (temperature ≥37·3°C) should have both chest CT and respiratory viral tests. Patients with normal chest CT scans can follow measure 1 interventions. If the consensus is bacterial community-acquired pneumonia (CAP), then standard clinical protocols are followed. Once the patient's temperature returns to normal, they are transferred to undesignated hospitals or discharged home (measure 2, figure). Patients diagnosed with viral pneumonia require isolation and SARS-CoV-2 tests (measure 3). Systemic and local respiratory defense mechanisms are compromised, resulting in bacterial co-infection if early, effective antiviral treatment is not started. Empirical therapy consists of oral moxifloxacin or levofloxacin (consider tolerance) and arbidol. Arbidol is approved in China and Russia for influenza treatment. In-vitro studies showed that arbidol had inhibitory effects on SARS.2Khamitov RA Loginova S Shchukina VN Borisevich SV Maksimov VA Shuster AM Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures.Vopr Virusol. 2008; 53: 9-13PubMed Google Scholar Patients testing positive for SARS-CoV-2 are transferred to designated hospitals. Dyspnoea and hypoxaemia suggest severe pneumonia and are suspicious even in afebrile patients. If presenting with dyspnoea and hypoxia (oxygen saturation [SpO2] <93%), prescribe supplemental oxygen, admit to an isolation ward, and assess transfer risk. If patients are deteriorating with measure 3 interventions, the core treatment principle we recommend is antiviral plus antipneumococcus plus anti-Staphylococcus aureus (measure 4, figure). Coverage for Streptococcus pneumoniae and S aureus is important as co-infection increases the likelihood of severe illness.3Hageman JC Uyeki TM Francis JS et al.Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season.Emerg Infect Dis. 2006; 12: 894-899Crossref PubMed Scopus (326) Google Scholar High-dose nemonoxacin (750 mg once daily) and linezolid is effective against S pneumoniae and Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus [MRSA]). Glucocorticoids are not a routine treatment.4Chen RC Tang XP Tan SY et al.Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience.Chest. 2006; 129: 1441-1452Summary Full Text Full Text PDF PubMed Scopus (249) Google Scholar In emergency cases, such as SpO2 <90%, dexamethasone 5–10 mg or methylprednisolone 40–80 mg is given intravenously before transfer. High-throughput oxygen therapy or continuous positive airway pressure (CPAP) ventilation are both effective supportive therapies and target blood SpO2 should be 88–90%. Invasive mechanical ventilation is used as a last resort. Special considerations are given for elderly, immunocompromised, and pregnant patients. Older patients (>65 years) and immunocompromised patients should be treated as moderate or severe cases in the initial assessment. Infections in pregnant women might progress rapidly and timely clinical decisions are crucial to provide pregnant women with options, such as induction, anaesthesia, and surgery. Consultation with an obstetric specialist is recommended and depending on the condition of the mother, termination of the pregnancy is a consideration. Home care and isolation can relieve the burden on health-care providers of fever clinics. We used this strategy in Wuhan in response to the large volume of patients arriving at health care centres but do not recommend it for other regions where each suspected case can be appropriately isolated and monitored in a health setting. Inappropriate home care can be life threatening for patients and be a detriment to public health.5WHO Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts.https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contactsDate accessed: February 7, 2020Google Scholar Many factors contributed to developing our clinical algorithm in Wuhan during the early outbreak period. During this time, the influx of patients to fever clinics substantially outweighed the number of physicians. Inpatient care was unsafe due to potential cross-infection and supplementary resources were not ready. Applying and waiting for results of an SARS-CoV-2 test was time consuming just after the outbreak and did not aid clinical decision making. We made trade-offs between infection control and standard medical principles and adapted the protocol as more information and resources became available. We hope our experience will serve as guidance for other fever clinics and future cases. We declare no competing interests. Download .pdf (.16 MB) Help with pdf files Supplementary appendix Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Full-Text PDF

Differential diagnosis of coronavirus disease 2019 from pneumonias caused by other etiologies in a fever clinic in Beijing

Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study

Retrospective analysis of the clinical features of outpatients with novel coronavirus in areas outside Wuhan, China

Epidemiological, Clinical, Laboratorial and CT Imaging Features of Hospitalized Patients with Initially Negative Detection of SARS-CoV-2 in China

Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)

Early Discern COVID-19 from the Suspected Patients Via Fever Clinics: A Multicenter Cohort Study from Shanghai

Comparison of the Clinical and CT Features Between COVID-19 and H1N1 Influenza Pneumonia Patients in Zhejiang, China

Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China

Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China

Discussion on the management of fever clinic during the epidemic period of corona virus disease 2019

Epidemiological Surveillance of Common Respiratory Viruses in Patients with Suspected COVID-19 in Southwest China.

Therapeutic and Triage Strategies for 2019 Novel Coronavirus Disease in Fever Clinics

Fever Clinic in Non-Epidemic Area During Coronavirus Disease 2019 Outbreak: an Analysis of Countermeasures

Analysis on Diagnosis, Treatment and Influential Factors in Fever Patients During Epidemic of Severe Acute Respiratory Syndrome

A Novel Artificial Intelligence-Assisted Triage Tool to Aid in the Diagnosis of Suspected COVID-19 Pneumonia Cases in Fever Clinics

Epidemiological and Clinical Characteristics of Suspected COVID-19 Patients in the Isolation Ward in Guangzhou, China: a Cohort Study.

Pathogenic analysis of suspected COVID-19 patients in a SARS-CoV-2 non-epidemic area of China

The differential diagnosis for novel coronavirus pneumonia and similar lung diseases in general hospitals

Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients

Computed Tomography and Clinical Features Differentiating Coronavirus Disease 2019 from Seasonal Influenza Pneumonia

COVID-19 versus non-COVID-19 pneumonia: A retrospective cohort study in Chengdu, China